Last SFr.5.61 CHF
Change Today -0.18 / -3.11%
Volume 4.5K
As of 11:43 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

new venturetec ltd-br (NEV) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/5/14 - SFr.6.75
52 Week Low
12/16/14 - SFr.4.40
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEW VENTURETEC LTD-BR (NEV)

Related News

No related news articles were found.

new venturetec ltd-br (NEV) Related Businessweek News

No Related Businessweek News Found

new venturetec ltd-br (NEV) Details

New Venturetec is a private equity and venture capital firm specializing in start up, early stage, mezzanine, IPO, and post-IPO investments across companies. The firm typically invests in venture companies in all stages from seed to late stage. It invests in private or public biotechnology and technology sector companies based in the United States with exceptional investments may be domiciled in Europe. The firm mainly invests in securities which are illiquid and are not traded on any stock markets. Investments are made in all classes of securities, including common and preferred equity, secured and unsecured debt, convertibles, options, warrants and combinations. The investment horizon of the firm may be as 3 to 20 years. New Venturetec was founded in August 8, 1997 and is based in Zurich, Switzerland.

Founded in 1997

new venturetec ltd-br (NEV) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

new venturetec ltd-br (NEV) Key Developments

New Venturetec Announces Earnings Results for the Year Ended September 30, 2014

New Venturetec announced earnings results for the year ended September 30, 2014. The company closed the fiscal year 2013/14, ended September 30, 2014, with a loss of USD 20,639,722, compared to a gain of USD 16,857,382 in the fiscal year 2012/13. The main reason for the loss was the decrease of the quoted share price of Osiris Therapeutics and a write down on the investment in mPortal. The net asset value per share decreased from USD 14.01 to USD 9.93 which equals -29.1% during the reporting period; in CHF respectively from CHF 12.67 to CHF 9.48 or -25.2%. The main reason for the loss was the decrease of the quoted share price of Osiris Therapeutics by 24.3% from USD 16.64 to USD 12.59 and a write down on the investment in the private company mPortal. The details on the valuation of the portfolio companies are described in the annual report.

New Venturetec to Report Fiscal Year 2014 Results on Nov 05, 2014

New Venturetec announced that they will report fiscal year 2014 results on Nov 05, 2014

New Venturetec, Annual General Meeting, Nov 25, 2014

New Venturetec, Annual General Meeting, Nov 25, 2014. Agenda: To propose the creation of up to CHF 15,000,000 of authorized capital by issuing 2,500,000 common shares at a par value of CHF 6.00 per share.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEV:SW SFr.5.61 CHF -0.18

NEV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEV.
View Industry Companies

Industry Analysis


Industry Average

Valuation NEV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.9x
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEW VENTURETEC LTD-BR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at